Effects of Reducing Indoor Air Pollution on the Adult Asthmatic Response

Not Applicable

Completed

Conditions: Asthma

Interventions: Device: High Efficiency Particulate Air Cleaner
Device: Sham air cleaner

Registration Number: NCT02153359

Lead Sponsor: Johns Hopkins University

Brief Summary: This study is about asthma and how the environment affects asthma. Scientists know that air pollution (such as cigarette smoke and other particles in the air) can make asthma symptoms worse. This research is being done to study how the health of a person with asthma responds to an air cleaner. The investigator hypothesize that an air cleaner will improve the health of persons with asthma.

Detailed Description: The investigators seek to determine the effect of placing air cleaner devices in the homes of adults with asthma on the adults' asthma health. To this end, the investigators aim to study 40 adults with asthma that are 18-50 years of age and live in Baltimore. Participants will receive either true air cleaners or sham cleaners in a blinded, randomized manner for one month, and then, after a washout period, participants will cross over and receive the other intervention (sham or true cleaner). All participants will have environmental monitoring (personal and in-home) to determine participants' particulate matter exposure, and be followed repeatedly during the 3 month study period for markers of asthma disease, including respiratory symptoms, medication and health care utilization, pulmonary function, systemic markers of inflammation, and bronchoscopic evidence of airway inflammation or epithelial cell dysfunction.

Recruitment & Eligibility

Status: COMPLETED

Sex: All

Target Recruitment: 23

Inclusion Criteria

Age 18-50 years of age
Non-smoker (<100 cigarettes in lifetime)
Physician diagnosis of asthma
Symptoms of asthma and/or reliever medication use in the past 6 months
Living in the current residence >= 6 months within Baltimore
Enrollment in, and completion of, the observational environmental asthma study "Inhale 1"

Exclusion Criteria

Current diagnosis of another major pulmonary disease, other significant morbidity
Pregnancy (as defined by a positive urine pregnancy test at screening of all women of child-bearing potential)
Planning to relocate residence or activity that necessitates travel away from home for prolonged period of time during the study period
Current use of an air cleaner in the home

Study & Design

Study Type: INTERVENTIONAL

Study Design: CROSSOVER

Arm && Interventions

Group	Intervention	Description
Air cleaner then sham air cleaner	Sham air cleaner	A High Efficiency Particulate Air Cleaner (HEPA) intervention will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the experimental arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the sham comparator arm.
Air cleaner then sham air cleaner	High Efficiency Particulate Air Cleaner	A High Efficiency Particulate Air Cleaner (HEPA) intervention will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the experimental arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the sham comparator arm.
Sham air cleaner then air cleaner	Sham air cleaner	A sham air cleaner will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the sham comparator arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the experimental arm.
Sham air cleaner then air cleaner	High Efficiency Particulate Air Cleaner	A sham air cleaner will be placed in the participant's home for one month. During the last week of the month, health assessments will be conducted, which include in-home health questionnaires, symptom-, and activity- diaries/recalls, blood, and hand-held spirometry. Participants will also be asked to wear a light backpack with air monitoring devices during the course of the day during the last week in order to measure participants' exposures to pollutants. Finally, at the end of the month, participants will be asked to report to the Johns Hopkins outpatient endoscopy suite for bronchoscopy, during which airway sampling will occur under conscious sedation. For the participants who started in the sham comparator arm, after this one month intervention period, they will then enter a wash-out period where no intervention or outcome measures are undertaken for at least one month prior to cross-over to the experimental arm.

Primary Outcome Measures

Name	Time	Method
PM2.5 Concentration (ug/m^3)	Approximately 1 month	Fine particulate matter (PM2.5) concentration as assessed by a passive filter placed in the participant's home.
PM2.5-10 Concentration (ug/m^3)	Approximately 1 month	Coarse particulate matter (PM2.5-10) concentration as assessed by a passive filter placed in the participant's home.

Secondary Outcome Measures

Name	Time	Method
Number of Symptom-free Days	7 days	The number of reported days without daytime asthma symptoms (symptom-free days) as based on daily symptom diaries recorded by the patient.
Number of Days With Activity Limitations	7 days	Number of reported days with activity limitations due to asthma symptoms.
Number of Nights Disrupted by Asthma Symptoms	7 nights	The number of nights spent sleeping that was disrupted due to asthma symptoms.
Number of Days of School/Work Missed Due to Asthma Symptoms	7 days	The number of days of school or work missed due to asthma symptoms.
Number of Days of Unscheduled Visits to the Doctor Due to Asthma Symptoms	7 days	The number of days of unscheduled, urgent visits to the office, urgent care or emergency department due to asthma symptoms.
Asthma Disease Status as Assessed by the Asthma Control and Communication Instrument (ACCI)	Approximately 1 month	The ACCI is a validated clinical tool that measures asthma disease status during routine health care and is valid for use in both black and white populations. The sum of each of the 5 ACCI asthma control domains results in a final ACCI score ranging from 0 (better control) to 19 (worse control).
Asthma-specific Health-related Quality of Life as Assessed by the Asthma Quality of Life Questionnaire (AQLQ)	Approximately 1 month	The AQLQ is validated clinical tool to assess asthma-specific health-related quality of life instrument that taps both physical and emotional impact of disease. Scores range from 1-7, with higher scores indicating better quality of life.
Air Nicotine Concentration (ug/m^3)	Approximately 1 month	Indoor air nicotine concentration as assessed by a passive filter placed in the participant's home.
Bronchoalveolar Lavage Differential Neutrophil Count	1 Day	The percentage of neutrophils in the bronchoalveolar lavage cell count.
Bronchoalveolar Lavage Differential Eosinophil Count	1 day	The eosinophil percentage in the bronchoalveolar lavage cell count differential.
Pre-bronchodilator Forced Vital Capacity (Litres)	1 day	Pre-bronchodilator forced vital capacity (FVC) as assessed with spirometry
Pre-bronchodilator Forced Expiratory Volume in 1 Second (Litres)	1 day	The pre-bronchodilator forced expiratory volume in 1 second (FEV1) as assessed by spirometry.
FEV1 Percentage of FVC	1 day	The pre-bronchodilator forced expiratory volume in 1 second over the forced vital capacity as assessed by spirometry.

Trial Locations

Locations (2): Johns Hopkins Bayview Medical Center
🇺🇸
Baltimore, Maryland, United States
Johns Hopkins Hospital
🇺🇸
Baltimore, Maryland, United States